Therapeutics Thursdays: MCM 2021 Clinical Feature: Old Drugs, New Drugs and New Evidence for Dyslipidemia Management

In this feature from the 2021 Midyear Clinical Meeting, our content matter experts share updates from the REDUCE-IT and STRENGTH trials and the role current therapies, as well as new and emerging therapies, play in managing dyslipidemia. The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.